PARTNERING
About Pilatus Biosciences
Our Story
Pilatus Biosciences, founded in 2022, pioneers first-in-class biologics targeting metabolic checkpoints to advance cancer immunotherapy. Drawing on groundbreaking research from the Ludwig Institute for Cancer Research (LICR) and the University of Lausanne (UNIL), the company drives transformative innovations in cancer treatment.
Supported by its U.S. holding entity, Pilatus Biosciences conducts cutting-edge research at the Biopôle campus in Epalinges, Switzerland, and manages strategic partnerships and developments through its subsidiary at Taipei Bioinnovation Park in Taiwan.
Governance
With a global presence, Pilatus Biosciences benefits from valuable competences around the globe and has built strong collaborations between teams, partners, and other stakeholders.
Delaware, USA
Delaware
Pilatus Biosciences Inc
874 Walker Road, Suite C, Dover, Country of Kent, Delaware 19904, USA
Lausanne, Switzerland
Taipei, Taiwan
Taipei
Pilatus Biosciences Corp
17F-1, No. 508, Section 7, Zhongxiao East Road, Nangang District, Taipei City 115, Taiwan
Lausanne, Switzerland
Pilatus Biosciences SA
Route de la Corniche 6
1066 Epalinges
Vaud - SWITZERLAND
Delaware, USA
Pilatus Biosciences Inc
874 Walker Road, Suite C, Dover, Country of Kent, Delaware 19904, USA
Taipei, Taiwan
Pilatus Biosciences Corp
17F-1, No. 508, Section 7, Zhongxiao East Road, Nangang District, Taipei City 115, Taiwan
“Pilatus is the name of a Swiss mountain in the Alps. Like scaling this iconic peak, we strive for top-level technology, push innovation's boundaries, uphold professionalism, and tackle challenges to achieve extraordinary heights.”
Now
Since 2023, the company has secured investments and funding to accelerate its growth, expanding both its business operations and R&D activities. Its scientific advancements have already earned endorsements from several reputable organizations. In 2025, Pilatus will continue to operate with a cross-border team and strategic external partnerships, enabling us to efficiently deliver innovative therapies to patients.
Company History Timeline
Mission
Our mission is to create innovative immunotherapies that unlock the immune system's potential and improve lives by turning once-untreatable diseases into manageable conditions.
Core Values
Innovation
Pioneering breakthrough science to develop novel therapies for unmet medical needs.
Impact
Improving human lives through excellence in medications.
.png)
Trust
Building confidence through integrity, accountability, and reliable execution.
Global Focus
Leveraging our worldwide presence to strengthen cross-border partnerships and business.
The Pilatus Biosciences Advantage
Pioneering in Immunometabolism
Pilatus is at the forefront of immunometabolism, developing novel therapies that modulate metabolic pathways within the disease-associated microenvironments to orchestrate immune function and tackle pressing unmet medical needs. This cutting-edge approach enables a new class of immunotherapies with broad applicability across oncology and metabolic disorders.
Framework of Global Alliances
Our lean, cross-border model is built on strategic collaborations with academic institutions, research hospitals, and industry partners. By integrating external innovation and expertise, Pilatus accelerates development while maintaining agility and operational efficiency.
Unlocking Immune Potential with
Innovative Metabolic Reprogramming
Pilatus Biosciences
Pilatus Biosciences SA
Route de la Corniche 6
1066 Epalinges
Vaud - SWITZERLAND
Route de la Corniche 6
1066 Epalinges
Vaud - SWITZERLAND
Pilatus Biosciences Corp
17F-1, No. 508, Section 7,
Zhongxiao East Road,
Nangang District,
Taipei City 115, Taiwan
17F-1, No. 508, Section 7,
Zhongxiao East Road,
Nangang District,
Taipei City 115, Taiwan
© 2025 Pilatus Biosciences. All Rights Reserved.